This review has comprehensively provided the anticancer potential of anthocyanins against different types of cancer, including breast, prostate, lung, liver, ovarian, and cervical cancers, by highlighting possible signaling pathways (MAPK, NF‐kB, and PI3k/Akt) and gene expression (TP53, BRCA1, and BCL‐2). The gene discussed is TP53; the disease is cancer.